NCT02605421 2025-10-21
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
Masonic Cancer Center, University of Minnesota
Phase 2 Recruiting
Masonic Cancer Center, University of Minnesota
Children's Hospital Los Angeles
Children's Oncology Group
Dana-Farber Cancer Institute
National Institutes of Health Clinical Center (CC)